NCT03980457 Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
| NCT ID | NCT03980457 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2021-09-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility.
Eligibility Criteria
Inclusion Criteria: 1. All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging. 2. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies. 3. Depressed patients will be included in the study 4. Patients able to stand alone 5. Patients able to provide a written informed consent, from cognitively intact patients (admission Mini Mental Scale Examination \[MMSE\] greater than or equal to 21). Exclusion Criteria: 1. Aphasic patients unable to communicate 2. Confused patients 3. Patients medically unstable 4. Patients unable to stand alone 5. Refusal to provide written informed consent
Contact & Investigator
Meheroz H Rabadi, MD, MRCPI
PRINCIPAL INVESTIGATOR
Affiliate; Oklahoma VA Health Care System
Frequently Asked Questions
Who can join the NCT03980457 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03980457 currently recruiting?
Yes, NCT03980457 is actively recruiting participants. Contact the research team at rabadimh@gmail.com for enrollment information.
Where is the NCT03980457 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT03980457 clinical trial?
NCT03980457 is sponsored by University of Oklahoma. The principal investigator is Meheroz H Rabadi, MD, MRCPI at Affiliate; Oklahoma VA Health Care System. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.